Retrospective cohort analysis finds adjuvant therapy improves glycemic control in type 2 diabetes, suggesting its viability in management.
The adjuvant TCM therapy is beneficial for achieving optimal glycemic control, suggesting that adjuvant TCM therapy may be embraced as a viable glycemic management approach for T2DM patients with poor glycemic control.
No takes yet. Share an insight, caveat, or question.
Shang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: